Molecular and serologic analysis of linked blood donor and recipient samples to rule out transfusion-transmitted parvovirus B19 infection.
Saved in:
| Title: | Molecular and serologic analysis of linked blood donor and recipient samples to rule out transfusion-transmitted parvovirus B19 infection. |
|---|---|
| Authors: | Miller MJ; Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, MD, United States., Virata ML; Plasma Derivatives Branch 2, Division of Plasma Derivatives, Office of Plasma Protein Therapeutics, Office of Therapeutic Proteins, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, United States., Yan H; Plasma Derivatives Branch 2, Division of Plasma Derivatives, Office of Plasma Protein Therapeutics, Office of Therapeutic Proteins, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, United States., Zhong L; Plasma Derivatives Branch 2, Division of Plasma Derivatives, Office of Plasma Protein Therapeutics, Office of Therapeutic Proteins, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, United States., Tarafdar S; Plasma Derivatives Branch 2, Division of Plasma Derivatives, Office of Plasma Protein Therapeutics, Office of Therapeutic Proteins, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, United States., Fowler S; Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, MD, United States., Zhang P; Plasma Derivatives Branch 2, Division of Plasma Derivatives, Office of Plasma Protein Therapeutics, Office of Therapeutic Proteins, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, United States., Alter HJ; Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, MD, United States., De Giorgi V; Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, MD, United States. |
| Source: | Frontiers in public health [Front Public Health] 2026 May 12; Vol. 14, pp. 1819397. Date of Electronic Publication: 2026 May 12 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Editorial Office Country of Publication: Switzerland NLM ID: 101616579 Publication Model: eCollection Cited Medium: Internet ISSN: 2296-2565 (Electronic) Linking ISSN: 22962565 NLM ISO Abbreviation: Front Public Health Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42205440 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Molecular and serologic analysis of linked blood donor and recipient samples to rule out transfusion-transmitted parvovirus B19 infection. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Miller+MJ%22">Miller MJ</searchLink>; Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Virata+ML%22">Virata ML</searchLink>; Plasma Derivatives Branch 2, Division of Plasma Derivatives, Office of Plasma Protein Therapeutics, Office of Therapeutic Proteins, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, United States.<br /><searchLink fieldCode="AU" term="%22Yan+H%22">Yan H</searchLink>; Plasma Derivatives Branch 2, Division of Plasma Derivatives, Office of Plasma Protein Therapeutics, Office of Therapeutic Proteins, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, United States.<br /><searchLink fieldCode="AU" term="%22Zhong+L%22">Zhong L</searchLink>; Plasma Derivatives Branch 2, Division of Plasma Derivatives, Office of Plasma Protein Therapeutics, Office of Therapeutic Proteins, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, United States.<br /><searchLink fieldCode="AU" term="%22Tarafdar+S%22">Tarafdar S</searchLink>; Plasma Derivatives Branch 2, Division of Plasma Derivatives, Office of Plasma Protein Therapeutics, Office of Therapeutic Proteins, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, United States.<br /><searchLink fieldCode="AU" term="%22Fowler+S%22">Fowler S</searchLink>; Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Zhang+P%22">Zhang P</searchLink>; Plasma Derivatives Branch 2, Division of Plasma Derivatives, Office of Plasma Protein Therapeutics, Office of Therapeutic Proteins, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, United States.<br /><searchLink fieldCode="AU" term="%22Alter+HJ%22">Alter HJ</searchLink>; Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22De+Giorgi+V%22">De Giorgi V</searchLink>; Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, MD, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101616579%22">Frontiers in public health</searchLink> [Front Public Health] 2026 May 12; Vol. 14, pp. 1819397. <i>Date of Electronic Publication: </i>2026 May 12 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Editorial+Office%22">Frontiers Editorial Office </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101616579 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2296-2565 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222962565%22">22962565 </searchLink><i>NLM ISO Abbreviation: </i>Front Public Health <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42205440 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fpubh.2026.1819397 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1819397 Titles: – TitleFull: Molecular and serologic analysis of linked blood donor and recipient samples to rule out transfusion-transmitted parvovirus B19 infection. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Miller MJ – PersonEntity: Name: NameFull: Virata ML – PersonEntity: Name: NameFull: Yan H – PersonEntity: Name: NameFull: Zhong L – PersonEntity: Name: NameFull: Tarafdar S – PersonEntity: Name: NameFull: Fowler S – PersonEntity: Name: NameFull: Zhang P – PersonEntity: Name: NameFull: Alter HJ – PersonEntity: Name: NameFull: De Giorgi V IsPartOfRelationships: – BibEntity: Dates: – D: 12 M: 05 Text: 2026 May 12 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2296-2565 Numbering: – Type: volume Value: 14 Titles: – TitleFull: Frontiers in public health Type: main |
| ResultId | 1 |